Smoke rings around useless research

Mental illness is still not proven to be caused by the behavior of parents nor by smoking more than average

Long time ago Klevius worked at Finland's biggest hospital for schizophrenic and mano-depressive patients. It was an isolation ward where the worst cases were held. During that time Klevius talked with all the patients whe were able to talk and carefully read through all more than 40 patient journals. What struck him was the fact that every patient had a history of clear mental illness either from their childhood (autism) or in their teens. None had suddenly become ill at adult age. Based on these findings plus the fact that Klevius grew up in a small town where some half of the visible population consisted of free going mental patients - and therefore gave him a quite good understanding of these kind of human vulnerabilities - he concluded that:

1 an absolute majority of schizophrenics and mano-depressives reveal clear signs before adulthood (even though the official diagnosis may come later). Getting these illnesses in adulthood is a tiny fraction (and often temporary) of the 1% general prevalence and could be due to virus (e.g. when giving birth) or self inflected via brain and nerve function damaging drugs etc.

2 the cause is never cultural but always biological (mostly genetic from birth or due to virus infection or a combination).

3 there is no cure to these illnesses, only medication that, if well assessed and targeted, may keep hallucinations and depressions at bay and help the individual live a normal, or at least more normal life. However, there is an enormous industry vulturing on these people. Not the least via the social state with its popular claim that "its the behavior of the parents". It's not (see the world's most important sociological paper Angels of Antichrist where Klevius deletes the lifework of Finland's perhaps most famous psychiatrist, Pekka Tienari). Becoming a "radical" muslim may well be traced back to the parents and would be an important field to study - schizophrenia and mano-depressivity may not.

Smoke ringed "science"

After analyzing almost 15,000 tobacco users and 273,000 non users and their relative rates of psychosis the "researchers" said cigarette smoking appears to increase risk.

James MacCabe, who co-led the research at King's College London's Institute of Psychiatry: "While it's always hard to determine the direction of causality, our findings indicate that smoking should be taken seriously as a possible risk factor for developing psychosis".

Klevius: Nothing could be more wrong! Your "findings" don't indicate that at all. It's you who distort your findings with your own as well as probably also your peers bias! The simple answer is that children/teens (e.g. autistic) with schizophrenic or mano-depressive tendencies are much more likely to be less socially and educationally "fluent" due to their underlying illness and therefore over represented in the outcast category that also contains less well adapted healthy children. And a well known fact is that this category always has had a higher incident of smokers than the normal (control) population.

Schizophrenia reflects abnormal dopamine fluctuations and mano-depressivity abnormal serotonin fluctuations. This fact is blurred by enemies of what they call the "dopamine hypothsis" by empty "indirect" or "direct" questionings without any real bearing at this stage before we know more.

The simplistic argument (could be applied to anything drug companies do) that drug companies have inappropriately promoted the dopamine "hypothesis" of schizophrenia as a deliberate and calculated simplification for the benefit of drug marketing, hides in fact, the very opposite, namely that it's the social state connected psychiatric mafia which makes huge money on useless "therapies" etc. that has grown even more powerful than even the biggest drug companies and their cartels. To understand this you again need to go back to Angels of Antichrist and the fact that money rolling in connection with state authority is far less controlled and far more dangerous.

Arvid Carlsson, Sweden's no 1 researcher, worked against the wishes of the social state but was saved by a private company

In 1957 (the same year Tienari made his infamous utterance about schizophrenia - see Angels of Antichrist) the Swedish scientist Arvid Carlsson was the first in the world to demonstrate that dopamine was a neurotransmitter in the brain and not just a precursor for norepinephrine. While working at the Swedish drug company Astra AB, Carlsson and his colleagues were also able to derive the first marketed selective serotonin re-uptake inhibitor, zimelidine, from brompheniramine.

Arvid Carlsson developed a method for measuring the amount of dopamine in brain tissues. He found that dopamine levels in the basal ganglia, a brain area important for movement, were particularly high. He then showed that giving animals the drug reserpine caused a decrease in dopamine levels and a loss of movement control. These effects were similar to the symptoms of Parkinson's disease. By administering to these animals L-Dopa, which is the precursor of dopamine, he could alleviate the symptoms. These findings led other doctors to try using L-Dopa on patients with Parkinson's disease, and found it to alleviate some of the symptoms in the early stages of the disease. L-Dopa is still the basis for most commonly used means of treating Parkinson's disease.

For his work on dopamine, Arvid Carlsson was awarded the Nobel Prize in Physiology or Medicine. However, due to the strength of the Swedish "psycho" social state (see Klevius) and its unwillingness to accept his groundbreaking research, he got it as late as 2000 and only together with two other researcher. But the Japanes, whose social state was nowhere even close to that of Sweden, had already back in 1994 awarded him with their highest prize in science and a bigger amount of money than he got from his homeland's Nobel committee. His Japan Prize was only the 10th given and was titled: 'Discovery of dopamine as a neurotransmitter and clarification of its role in mental and motor functions and their disorders'.